Dr. Marc Roig, Ph.D.
Claim this profileClinical Trials Marc Roig, Ph.D. is currently running
More about Marc Roig, Ph.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Marc Roig, Ph.D. has experience with
- Cardiovascular Training (CT)
- Multimodal Training (MT)
- Resistance Training (RT)
Breakdown of trials Marc Roig, Ph.D. has run
Motor Skills
Parkinson's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Roig, Ph.D. specialize in?
Marc Roig, Ph.D. focuses on Motor Skills and Parkinson's Disease. In particular, much of their work with Motor Skills has involved treating patients, or patients who are undergoing treatment.
Is Marc Roig, Ph.D. currently recruiting for clinical trials?
Yes, Marc Roig, Ph.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Marc Roig, Ph.D. has studied deeply?
Yes, Marc Roig, Ph.D. has studied treatments such as Cardiovascular training (CT), Multimodal training (MT), Resistance training (RT).
What is the best way to schedule an appointment with Marc Roig, Ph.D.?
Apply for one of the trials that Marc Roig, Ph.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.